- GILD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $1.4 billion.
- GILD traded 400,383 shares today in the pre-market hours as of 8:01 AM.
- GILD is down 8.4% today from yesterday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in GILD with the Ticky from Trade-Ideas. See the FREE profile for GILD NOW at Trade-Ideas More details on GILD: Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. GILD has a PE ratio of 18.2. Currently there are 15 analysts that rate Gilead a buy, no analysts rate it a sell, and 3 rate it a hold. The average volume for Gilead has been 14.9 million shares per day over the past 30 days. Gilead has a market cap of $154.5 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.11 and a short float of 3.7% with 4.11 days to cover. Shares are up 40.5% year-to-date as of the close of trading on Thursday.